Micronutrient testing: what whole blood shows and the serum value can miss
Measuring instead of guessing sounds simple. Until you notice that the same blood draw can give different answers depending on the tube, the hour and the marker.
A laboratory value is not a diagnosis. It is a snapshot from a tiny section of your body. The question is rarely whether your value lies inside the reference range. The question is whether we looked in the right place at all.
You are sitting in the consulting room. On the printout there is a column of numbers and next to it a column of reference ranges. Not a single value is flagged. The doctor says the sentence you already know: “Everything is in the green.”
And you walk out and you are still tired.
I know this situation from both sides of the desk. As a physician with a number in front of me that looks unremarkable. And as a person who knows that the body is not much impressed by a reference range.
This text is about what a micronutrient analysis can do and what it cannot. It is not a plea for more laboratory work. It is a plea for more precise laboratory work: fewer numbers, but the right ones.
What you will find here
- Why “normal” is a statistical term and not a state of your cells
- Serum, whole blood, erythrocytes: what each material can show
- Functional markers: measuring the work rather than the store
- Holo-transcobalamin, methylmalonic acid, homocysteine for B12 and folate
- Why ferritin without CRP gives only half an answer
- Omega-3 index and 25-OH vitamin D as well defined values
- Hair mineral analysis and IgG food tests, calmly sorted
- Pre-analytics: time of day, haemolysis, inflammation, fasting
“Normal” is a statistical term, not a state of your cells
Let us start with what creates this misunderstanding.
A reference range does not come about because somebody worked out which value is good for you. It usually comes about like this: a laboratory measures a parameter in a larger group of people who count as healthy, and defines the range into which the middle 95 percent fall. That is a sensible statistical convention. It is not a statement about an optimum.
Two things follow from this, and both are uncomfortable.
First: five percent of healthy people lie outside the range by definition. If you have twenty parameters determined, you should expect on purely arithmetic grounds that about one of them looks abnormal without anything being meaningful. That is why I think little of indiscriminate large panels. They produce chance findings that create fear and pull follow-up diagnostics behind them.
Second: the reference group lives in the same world as you. If a nutrient is broadly scarce in a population, the reference range migrates downwards with it. The range then describes what is usual, not what would be favourable. This distinction between average and optimum is the core of this whole topic.
“Inside the reference range” means: you are not conspicuously different from the comparison group.
It does not automatically mean: your cells have enough. And it does not mean that your symptoms have no physical basis. Holding both thoughts together is more demanding, but it is more honest.
Now comes the second level, and that one matters even more. Your body actively holds certain blood values constant. Not so that the number looks nice, but because heart rhythm, nerve excitability and clotting depend on it.
We call this homeostasis. And it is the reason why a blood value is sometimes the last thing to change.
A specialist review gathered how the body distributes magnesium and why assessing its status is so difficult. By far the largest share of magnesium sits intracellularly and in bone. Less than one percent floats in serum.
When the level in the blood threatens to fall, the body can deliver magnesium from the bone depot. For your heart that is good news. For diagnostics it is inconvenient, because the value can look normal while the reserves are already shrinking.
The authors also describe that the common measurement methods each have weaknesses of their own and that a generally accepted gold standard is missing. That is not a footnote, it is the central limitation of this field.
Workinger JL et al. Nutrients. 2018. DOI: 10.3390/nu10091202The same logic applies to other nutrients, only with different numbers. Potassium sits almost entirely inside the cell. Zinc is steered through a narrow control loop. By current understanding, selenium is transported preferentially to the organs that need it most urgently.
And from that follows the point that stands above this whole guide: a nutrient is not a switch. It is a player in a network. Whoever turns one screw moves others along with it.
The body regulates nutrients in circuits, not in sliders. That is why supplementing without knowing the starting point is an intervention and not a small matter.
And now you know why “everything is normal” and “I do not feel well” do not have to be a contradiction.
Serum or whole blood: why one blood draw can give two answers
Picture a river running through a city. You want to know how much water is available to the city. So you measure the level in the river.
That is serum.
What you do not see with it: the tanks in the cellars, the tanks on the roofs, the water in the pipes of the houses. That is exactly where everyday life happens. On top of that, the river level is actively regulated so that it does not swing about.
Whole blood is the attempt to count the water in the houses as well. Besides plasma it also contains the cells, above all the red blood cells. For minerals that sit mostly inside the cell, this can be a sensible addition.
Now comes the limitation that is rarely supplied in the advertising for such analyses and that I consider the most important part.
Whole blood is not a gold standard. The reference ranges differ between laboratories. The haematocrit, meaning the share of cells in the blood, influences the result. And for many parameters there are no large studies showing that the whole blood value allows better clinical predictions than the serum value. What we can say with confidence: it is a different angle. What we cannot seriously say: it is always the better one.
| Material | What it can show | Where the limit sits |
|---|---|---|
| Serum or plasma | The share currently circulating in the blood. Well suited for acute derailments and for parameters that really are transported outside the cells. | Tightly regulated for several minerals. Can look normal while the tissue stores are falling. |
| Whole blood | Plasma plus cell content. Can add information for intracellular minerals such as magnesium, potassium, zinc and selenium. | No accepted gold standard, laboratory dependent reference ranges, influence of the haematocrit. |
| Erythrocytes | The content of the red blood cells. Standard for the omega-3 index, because the membrane reflects intake over the medium term. | More elaborate, more expensive, established and standardised for only a few parameters. |
| Functional markers | Metabolic products that rise or fall when a nutrient runs short. Examples: methylmalonic acid, homocysteine. | Not specific for a single nutrient. Kidney function, thyroid and medicines can have a say. |
| Hair | Established in standardised toxicological procedures for specific questions. | For judging nutrient status with commercial mineral profiles it does not hold up according to the available data. |
Many people look for the one correct value. The laboratory seems to deliver exactly that: a number with one decimal place.
Only, each material measures a different question. Serum asks: what is circulating right now? Whole blood asks: what is inside the cells? A functional marker asks: is the metabolism running smoothly? Those are three different questions, and they are allowed to lead to three different answers.
And now you know why the question “whole blood or serum” can so rarely be answered with a single word.
Functional markers: measuring the work rather than the store
Here comes the idea that, for me, brought the biggest change in nutrient diagnostics.
Picture a kitchen. You want to know whether there is enough flour. You can look into the pantry and count the sacks. That is the concentration measurement.
Or you look at what comes out of the kitchen. If half-finished doughs are suddenly standing around everywhere, then something is missing somewhere in the process. That is a functional marker.
This is exactly how methylmalonic acid and homocysteine work. Both are intermediates in metabolism that can pile up when an enzyme is not running smoothly because a cofactor is missing.
Methylmalonic acid (MMA)
Rises when a B12 dependent enzyme in the mitochondrion starts to stall. It counts as a comparatively specific pointer towards a functional B12 deficiency.
Limitation: reduced kidney function and a bacterial overgrowth in the small intestine can lift the value as well.
Holo-transcobalamin
Measures the share of B12 bound to the transport protein transcobalamin, which can therefore actually reach the cells. It is discussed as an early marker.
Limitation: this value too has no perfect discrimination, and the cut-offs differ from laboratory to laboratory.
Homocysteine
Rises when folate, B12 or B6 run short. A summarising look at several B vitamins at once, well studied and widely available.
Limitation: not specific. Kidney function, thyroid, smoking, coffee, genetics and medicines can all play a part.
Zinc protoporphyrin
Arises when zinc instead of iron is built into the red blood pigment. In practice it is used as a pointer towards iron deficient blood formation.
Limitation: as a lone marker its meaning is limited, useful only in combination with other parameters of the red cell series.
Omega-3 index
The share of EPA and DHA among the fatty acids of the erythrocyte membrane. It reflects the medium term supply and not the last meal.
Limitation: the method has to be standardised, otherwise values are hard to compare between laboratories.
25-OH vitamin D
The storage form with a long half-life. It is the established status marker, not the active form calcitriol.
Limitation: the measurement methods differ noticeably between laboratories, despite international efforts at standardisation.
A laboratory in Liechtenstein evaluated more than 11,800 blood samples in which total B12, holo-transcobalamin, methylmalonic acid and homocysteine had been determined at the same time.
For detecting a subclinical B12 deficiency, holo-transcobalamin performed best overall, followed by methylmalonic acid and total B12. Homocysteine lagged clearly behind. The lead of holo-transcobalamin was clearest in women aged 50 and over. In men and in younger women the markers did not differ in a statistically meaningful way.
Two things belong to an honest reading here. First, the yardstick used was a calculated index into which holo-transcobalamin itself feeds. The marker is therefore measured partly against itself, and that can make its lead look larger than it is. Second, the work comes from a commercial laboratory that offers these tests. Neither devalues the study, but both belong placed beside it.
What that means for you: the more expensive marker is not automatically the better one. It can contribute more in certain groups and for certain questions. That selection is a medical decision that follows from your question and not from the cut of a test package.
Jarquin Campos A et al. Dis Markers. 2020. DOI: 10.1155/2020/7468506There is a second piece of work that lights up the point from another direction, and I am showing it to you because it makes the limits visible.
A Scottish working group evaluated laboratory requests from primary care and assigned to each request the clinical question behind it: nerve complaints, anaemia, cognitive decline, suspected nutritional deficiency.
Methylmalonic acid served as the reference. The result: the diagnostic discrimination of total B12 and holo-transcobalamin varied considerably depending on the question. For anaemia and cognitive decline, total B12 came close to chance, while holo-transcobalamin distinguished better.
Honest interpretation belongs here too: one of the authors is connected with the manufacturer of the holo-transcobalamin test that was examined. And the authors themselves stress that the cut-offs used can explain part of the difference. Precisely this caution makes the work valuable: it does not deliver a winner, it delivers an argument for clarifying the question before the test.
Murphy MJ et al. Ann Clin Biochem. 2021. DOI: 10.1177/00045632211003605A functional marker is not a better number. It answers a different question.
The concentration asks: how much is there? The functional marker asks: is it enough for the work that is due right now? In a person under heavy load, the second question can be the decisive one.
And now you know why in some people I put more weight on methylmalonic acid than on B12 in serum.
Vitamin B12: the value that raises the alarm late
If one topic shows that “measuring instead of guessing” is more than an advertising slogan, it is this one.
Total B12 in serum measures two things at once. It measures the smaller part bound to transcobalamin, which can actually reach the cells. And it measures the larger part that hangs on haptocorrin and is barely available to the cell.
Picture a delivery fleet. One part of the vehicles drives to the houses and delivers. Another part stands in the yard and gets counted. If you count both together, the fleet looks bigger than the delivery performance.
A review from American haematology sums up the situation soberly. The common measurement methods for total B12 do not always reflect the actual stores reliably.
Surrogate markers such as methylmalonic acid and homocysteine can improve detection, but taken on their own they are not very specific. For holo-transcobalamin, too, the authors see somewhat better sensitivity, while the specificity is not yet conclusively settled.
What that means for you: there is no single test here that answers everything. The combination of symptoms, risk profile and two or three fitting markers says more than any single number.
Oberley MJ, Yang DT. Am J Hematol. 2013. DOI: 10.1002/ajh.23421Who is particularly affected? People who eat vegan, because B12 in relevant amounts comes from animal sources. People taking proton pump inhibitors, because stomach acid is needed to release it from food. People on metformin. People after stomach or bowel surgery. And people at an older age, in whom stomach acid production often declines.
This list is not a reason for alarm. It is a reason to look in a targeted way instead of supplementing across the board.
Now comes a point that matters to me, because it shows homeostasis in its purest form.
Folate and B12 work in the same metabolic pathway. If a lot of folic acid is taken in while B12 is short at the same time, blood formation can improve on the surface while the B12 deficiency runs on.
And that is why I am being clear here: a B12 deficiency left untreated for longer can damage the spinal cord. It is called subacute combined degeneration, in German funikuläre Myelose. It can show up first as tingling, numbness or an unsteady gait, and after it has persisted for longer it may no longer resolve completely. Whoever supplements folic acid should therefore know their B12 status beforehand.
This discussion has run for decades, and it is not closed. A review from neurology sees a real risk in this and calls for a reassessment of the upper intake level for folic acid (Reynolds 2016). A later toxicological review contradicts that reading and considers the current upper limit sufficiently supported (van Gool 2020).
I am showing you both sides because I do not want to pretend to a certainty that does not exist on this question. The common denominator of both camps is exactly the sentence above: whoever supplements folate should know their B12 status. For me that is not a matter of taste.
One more thing matters: if a B12 deficiency is found, the question of its cause belongs with it. An autoimmune gastritis can sit behind it, what used to be called pernicious anaemia. It can make a different form of intake necessary than a capsule, and it can call for a medical work-up of the stomach.
And one more detail that is often overlooked in practice: if supplementation with B12 has already begun, measuring total B12 is barely interpretable any more. The value is then high, regardless of how the supply looked beforehand. Functional markers are the more helpful choice in this situation, and they too need some distance in time from the last intake.
A laboratory value taken after supplementation has begun no longer answers the question you came with.
And now you know why it is worth measuring before the first preparation and not after it.
Ferritin without an inflammation marker gives only half an answer
Hardly any value is misread as often as this one. And hardly any has so much to do with quality of life.
Ferritin is the storage protein for iron. A low value speaks for empty stores, that is undisputed. And here comes the sentence I leave out of no consultation: a newly found iron deficiency is not a finding you simply top up. It is a question. Namely: where is the iron being lost?
In men and in women after the menopause, answering it usually includes a medical work-up of the gastrointestinal tract, because a silent bleed can sit behind it, including one arising from a polyp or a tumour. In women before the menopause, menstrual bleeding is the most common reason, but that too deserves to be looked at once. Coeliac disease or impaired absorption in the gut can also be behind it. Taking iron without having asked this question can make the value look good and cover up the cause.
The problem also begins at the other end, though.
Ferritin is at the same time an acute phase protein. With inflammation it rises, regardless of how much iron is actually available. A cold last week, a silent inflammation in the abdomen, excess weight, an autoimmune disease: all of that can lift the value.
The result is treacherous. The ferritin value looks decent, and the iron supply to blood formation is not. There is a term of its own for this state, functional iron deficiency.
An international project called BRINDA brought together data from 26 population surveys, with almost 30,000 preschool children and around 25,700 women of childbearing age.
Depending on the survey, a raised CRP was detectable in 6 to 40 percent of the children and in 8 to almost 30 percent of the women. For the second inflammation marker AGP the shares were in part even higher. Obesity, meaning a BMI of 30 or above, was repeatedly linked with a raised CRP in the women.
Important for context: these data come mostly from countries with a high infection burden, malaria among them. The shares given therefore cannot be transferred to a practice in Berlin, and how common a silent inflammation is here is something these numbers do not say.
What does transfer is something else, namely the principle, and it is at the same time the working group's own conclusion: inflammation markers should be measured alongside, because otherwise nutrient values get sorted wrongly. That holds for your own result too.
Merrill RD et al. Am J Clin Nutr. 2017. DOI: 10.3945/ajcn.116.142315And then there is the question of the cut-off itself. It is more uncomfortable than it sounds.
A working group at the American health authority used data from the large population survey NHANES, evaluating a good 2,500 young children and around 7,500 non-pregnant women.
Instead of leaning on expert opinion, they searched for the point at which haemoglobin begins to fall and the soluble transferrin receptor begins to rise, meaning the start of iron deficient blood formation. This point lay at about 20 micrograms of ferritin per litre in children and at about 25 in women.
The thresholds in common use until then lay at 12 and 15. The authors stress that these values still have to be checked in other populations. It is not a new cut-off for practice, but it is a strong argument for not ticking off a value of 20 as unremarkable by reflex.
Mei Z et al. Lancet Haematol. 2021. DOI: 10.1016/S2352-3026(21)00168-XWhat follows from this in practice? A ferritin value without an accompanying inflammation marker is hard to interpret. Alongside it, a blood count, transferrin saturation and, depending on the question, markers of the red cell series such as the haemoglobin content of reticulocytes or zinc protoporphyrin make sense.
A high ferritin value does not automatically mean: you have enough iron. It means, to begin with: there is a lot of storage protein in the blood.
Why it is there, whether as a store or as an inflammation signal, only the context can tell you. That is exactly the difference between a value and a finding.
And if a ferritin value is clearly raised without an inflammation that would fit, that belongs in medical hands too. An iron storage disease, a liver disease or a disease of the blood system can sit behind it, among others.
And now you know why with exhaustion I almost never order a ferritin on its own.
Omega-3 index and 25-OH vitamin D: two values that are well defined
After so much caution it is time for the other side. There are parameters where the measurement is pleasingly clear. I use two of them regularly.
The omega-3 index
Here it is not the plasma that is measured but the membrane of the red blood cells. The reason is elegant: an erythrocyte membrane is built up over weeks. So it does not tell you what you ate yesterday, it tells you how your supply looked on average.
The index states what share EPA and DHA make up of all the fatty acids in the membrane. And unlike with many nutrient markers, here there are data linking the value to a hard endpoint.
A working group calculated, on the basis of a large pooling of cohorts, how the omega-3 index relates to the risk of fatal coronary heart disease. Ten cohorts could be used.
Per rise of one standard deviation, the relative risk fell by about 15 percent. Between the bottom and the top fifth the index lay at about 4.2 versus 8.3 percent. From this the authors estimated a marked risk difference between an index of 4 and one of 8 percent.
Important for sorting this: these are observational data. They show an association, not proof of cause and effect. The first author is also connected to a laboratory that offers this test. Both belong to an honest appraisal.
Harris WS et al. Atherosclerosis. 2017. DOI: 10.1016/j.atherosclerosis.2017.05.007A smaller study from Erlangen fits the picture. In 71 people with symptoms who had a computed tomography of the coronary arteries, the omega-3 index was lower in those with strongly pronounced calcification than in the rest. The authors write themselves that this finding has to be confirmed in larger groups. I am showing it to you as a piece of the puzzle, not as proof (Bittner 2020).
25-OH vitamin D
With vitamin D people often ask why the active form is not measured. The answer has to do with homeostasis again: the active form is tightly regulated through parathyroid hormone and can even look high normal in a deficiency. The storage form 25-OH vitamin D has a clearly longer half-life and reflects the supply better.
But modesty applies here too, for a reason that hardly anyone has on their radar.
A review by two specialists from the USA and the United Kingdom describes the state of standardisation for 25-OH vitamin D. An international programme has developed reference methods and standard materials so that results become comparable.
Even so, the conclusion runs, a considerable scatter of measured values persists in clinical laboratories. The existing guidelines rest largely on non-standardised data, which is why a consensus on the boundaries between deficiency, sufficiency and excess is not in sight for now.
What that means for you: comparisons over time say more when they come from the same laboratory. And a single value close to a boundary is no reason for hectic action.
Binkley N, Carter GD. Endocrinol Metab Clin North Am. 2017. DOI: 10.1016/j.ecl.2017.07.012With selenium there is a similar subtlety that I find interesting. The concentration in serum is a pointer. As a more functional marker, the transport protein selenoprotein P is discussed, which can mirror the supply to the organs and can run into a plateau once intake is sufficient. A review from Berlin describes this in detail (Schomburg 2022). For broad practice, however, this marker is not yet standard.
Not every value is equally well defined. With the omega-3 index and with 25-OH vitamin D we know comparatively precisely what we are measuring.
With intracellular minerals the picture is blurrier. That is no reason not to measure. It is a reason to treat the results with different degrees of confidence.
And now you know why I follow some values over time and others only once for orientation.
What an analysis cannot do: hair mineral analysis and IgG tests
Now the part where I risk disappointing you. I am writing it anyway, because you are offered both of these on every corner of the internet.
And first of all: if you have had one of these tests done, that is not a reproach. They are marketed professionally, they look scientific, and the longing for an answer is entirely understandable.
The hair mineral analysis
The idea sounds good. Hair grows over months and should therefore contain a kind of long term record. For individual substances in strictly standardised toxicological procedures, that is indeed established.
For commercial mineral profiles the data look different.
A working group at the Californian health authority took a hair sample from a healthy person, divided it and sent the portions to six commercial laboratories which together covered about 90 percent of the US market for mineral analyses.
For twelve minerals the highest and the lowest reported value differed by more than tenfold. For 14 of 31 minerals there were statistically striking extreme values. The reference ranges also differed strongly, so that almost every mineral was classified as high, normal or low depending on the laboratory. The laboratories then gave dietary and supplement recommendations that contradicted one another.
The authors expressly advised against using such analyses to judge an individual nutrient status or suspected environmental exposures.
Seidel S et al. JAMA. 2001. DOI: 10.1001/jama.285.1.67This study is old, that is true. To this day I know of no comparably designed work showing that reproducibility between the laboratories has clearly improved. As long as that remains so, I hold to this appraisal, and I will gladly change it if new data suggest it.
IgG and IgG4 tests on foods
Here the matter is immunologically even clearer, and in a certain way it is comforting.
A working group of the European Academy of Allergy and Clinical Immunology summarised the state of knowledge. Their result in one sentence: IgG4 against foods shows that your immune system has met these foods repeatedly.
Many people have positive values without any matching symptoms. For a triggering role in intolerances, the group judges that the basis is missing. They sort IgG4 rather as a sign of immunological tolerance, connected with the activity of regulatory T cells.
Their recommendation is unambiguous: such tests are not relevant for working up food-related complaints and should not be used for that purpose.
Stapel SO et al. Allergy. 2008. DOI: 10.1111/j.1398-9995.2008.01705.xIf a test is not up to the job, that says nothing about your symptoms. Your bloating, your tiredness after eating, your brain fog are real.
It only means: this test gives the wrong answer to them. And a wrong answer is worse than none, because it ends a search that should carry on. More useful are a structured elimination and reintroduction phase with medical guidance, a work-up for coeliac disease and carbohydrate handling, and a look at stomach acid, bile flow and the microbiome.
And now you know why I prefer to test less and to take seriously what has been tested.
Pre-analytics: time of day, haemolysis and the half story in the tube
Now comes the least spectacular section of this text. And perhaps the one with the most practical effect.
Pre-analytics is everything that happens before the actual measurement: the time of day, whether you are fasting, how long the tourniquet was on your arm, how the tube was transported, how quickly it was centrifuged. And this part decides the result more often than most people suspect.
One example every practice knows: haemolysis. When red blood cells burst during the draw or during transport, they release their content into the serum. And because potassium sits mostly inside the cell, the measured value then rises without anything having changed in the body. For other intracellular parameters the same effect can play a role.
A Croatian working group produced haemolysis in different ways and measured the same samples on three different analysers. They checked from which degree of haemolysis the deviation was no longer acceptable.
Potassium and lactate dehydrogenase were affected on all three devices even with slight haemolysis. From somewhat higher haemolysis onwards, glucose, sodium, chloride and phosphate joined them. And the sensitivity differed depending on the device and on how the haemolysis had come about.
An Indian working group reached a similar conclusion in 25 sample pairs: for potassium, sodium, phosphate, total protein and LDH, haemolytic samples should in their view not be evaluated at all.
Nikolac Gabaj N et al. Clin Chem Lab Med. 2022. DOI: 10.1515/cclm-2021-1227 · Bhargava S et al. Indian J Clin Biochem. 2020. DOI: 10.1007/s12291-019-00821-4With homocysteine there is a related problem that is even more subtle. Red blood cells keep releasing homocysteine after the blood draw. If the sample stands too long before plasma and cells are separated, the value rises. An international expert panel has published a detailed guidance document on this (Refsum 2004), covering exactly such practical questions: sample collection, handling, biological influences, reference ranges and the variation within one and the same person.
With zinc it is the time of day and the last meal. An international expert panel describes in its report that the plasma concentration is influenced by meals, time of day, inflammation and certain medicines and hormones. The same panel also records that the data for hair, urine, nail and blood cell values are so far not sufficient to recommend them for judging zinc status.
An international expert panel within the BOND project worked through what zinc status can actually be judged by. Three approaches are recommended: intake from the diet, the plasma concentration and, in children, growth in length.
On the plasma concentration they name clear limitations: considerable variation between individuals, a smaller response to zinc from foods than to a preparation taken between meals, plus influences of meals, time of day, inflammation, medicines and hormones.
What that means for you: a single zinc value in the afternoon after lunch does not carry much weight. Standardisation here is not a detail, it is the precondition for the number meaning anything at all.
King JC et al. J Nutr. 2016. DOI: 10.3945/jn.115.220079One last example that convinced me particularly, because it recreates the serum versus whole blood question directly in the laboratory.
A Scottish working group examined in the test tube what the distribution of pyridoxal phosphate, the active form of vitamin B6, between plasma and red blood cells depends on. Blood from eight healthy people and 26 severely ill patients was used.
Result: the lower the albumin, the less pyridoxal phosphate stayed in the plasma and the more was found in the red blood cells. Alkaline phosphatase worked in the opposite direction.
The authors' conclusion: with low albumin, as often occurs in inflammatory states, the value in the red blood cell can distinguish more reliably between a real and an only apparent B6 deficiency than the plasma value. This is a laboratory investigation, not a clinical study. But it explains very precisely why the question of the material is not marketing.
Talwar D et al. Clin Nutr. 2020. DOI: 10.1016/j.clnu.2019.12.012Before you argue about how to interpret a value, clarify how it came about. Time of day, fasting, inflammation, sample quality and laboratory all have a say.
And now you know why with follow-up checks I insist that they happen under conditions as similar as possible.
The four lenses: what a laboratory value tells you about your system
In clinical psychoneuroimmunology we look at a symptom through four lenses. With nutrient diagnostics that is not a philosophical detour but a very practical sorting aid. It stops us from looking at a value in isolation.
Nervous system
B12 and folate are needed to maintain the myelin sheaths and for methylation. A functional deficiency can show up as tingling, odd sensations and trouble concentrating, while the blood count still looks unremarkable. That is why functional markers here often say more than the concentration alone.
Immune system
Inflammation changes laboratory values directly. Ferritin rises as an acute phase protein, zinc and selenium in plasma can fall because they are redistributed. Without CRP as an accompanying value you are therefore reading not the nutrient status but partly the inflammatory situation.
Metabolism
Iron, B vitamins and magnesium are cofactors in the energy production of the mitochondrion. When something runs short here, it can show up among other things as diffuse exhaustion. Exhaustion has many possible causes, though, and a nutrient shortfall is only one of them and rarely the first that belongs checked. Exactly this unspecific complaint brings people to the laboratory, and exactly it needs sorted diagnostics.
Hormone system
For the normal function of the thyroid, iodine and selenium are recognised as necessary. For iron and zinc an influence on thyroid metabolism is discussed, the data on this are thinner and do not allow a firm statement. Chronic stress can influence the excretion of magnesium through the adrenal axis, although the data on this are largely mechanistic. And kidney function influences how functional markers such as methylmalonic acid and homocysteine are to be read. None of this stands on its own.
And because exhaustion is the complaint that brings most people to the laboratory, a clear order belongs here. Before I think about micronutrients, other things belong checked: an underactive thyroid, an anaemia together with the question of its source, disturbed sleep including pauses in breathing at night, a diabetes, a depression, a heart or kidney disease, coeliac disease, a recent infection. This is not a box-ticking exercise. Whoever skips this level and orders the larger nutrient panel straight away can lose months.
These four lenses explain why I ask the same question before every analysis: what exactly do I want to know, and what changes if the answer comes out one way or the other?
Covering requirements and therapeutic high dose are two different worlds
At this point a distinction belongs that almost always blurs in public discussion.
Food supplementation in the narrower sense fills gaps. Those are the doses you buy in the drugstore or online. They orient themselves on reference values from bodies such as the German Nutrition Society or authorities such as EFSA. No therapeutic effect is to be expected from them, and that is not their job either.
Orthomolecular medicine means something else: clearly higher doses, used in a targeted way, limited in time, under medical supervision and with laboratory monitoring. Only in this range can a nutrient behave like a medicine, with everything that comes with it, side effects included.
An example makes the difference tangible. To cover requirements, the usual vitamin D doses lie in the range of about 800 to 2,000 international units per day, the order of magnitude in which reference values from specialist societies and common preparations move. Alongside this there are experimental high-dose concepts in which a multiple of that amount is used.
I deliberately do not give concrete figures here, and I do not describe the procedure either. What you should know: in higher strengths, vitamin D is prescription-only in Germany, so it is no longer a drugstore item. Such doses are not an established standard and are not recommended in guidelines.
Without medical supervision they can trigger hypercalcaemia, meaning a calcium level in the blood that is too high. Out of that can come kidney stones, calcification of kidney tissue, kidney failure and cardiac arrhythmias. A permanently strict calcium restriction is not harmless either, because over time it can put a strain on bone. I mention this example purely as an illustration of the dose principle and expressly not as a recommendation.
The point is: the same substance, two completely different applications. And that is why for the second application laboratory work is not optional, it is a precondition.
Why real food comes first
I say this in every conversation, and I mean it exactly like this: from real food of good origin, nutrient supply is the first choice. Not out of nostalgia, but because a food delivers nutrients in a matrix of cofactors that a capsule does not rebuild.
No supplement replaces nutrition, sleep, movement, sunlight and relationship. If someone comes to me with fifteen preparations and four hours of sleep, the analysis is rarely the most urgent building site.
And why topping up is nevertheless more often justified today
At the same time it would be dishonest to write off supplements across the board. There are reasons why targeted topping up can make sense more often today than fifty years ago.
First, the foods themselves. There are comparisons across decades that suggest lower contents of individual nutrients in fruit and vegetables. These comparisons have clear weaknesses: old and new analytical methods are hard to set against each other, and part of the effect may be explained by higher yielding varieties in which the same mineral is spread over more mass. I regard this as a signal that can be taken seriously. As proof it does not hold, and from it alone I would not derive any supplementation.
Second, the composition of what lands on the plate. Heavily processed foods as a rule deliver plenty of energy and little micronutrient density. Dietary surveys in Western countries describe a high share of energy intake for them. That too is a way of sorting the picture and not evidence that a deficiency follows from it in you.
Third, consumption. Environmental exposures such as heavy metals, mould toxins, plasticisers and pesticide residues, along with chronic stress, can raise the need for protective substances such as zinc, selenium, magnesium and glutathione precursors. This is a consideration I find clinically plausible. Solid studies that put a number on this extra need in humans are, for most of these factors, not known to me.
Fourth, the medicines. For some regularly taken substances an influence on the nutrient household is described. It is best studied for proton pump inhibitors, that is acid blockers with substances such as omeprazole or pantoprazole, where an influence on the uptake of vitamin B12 and magnesium is described, and for metformin, where an influence on B12 uptake is described.
For diuretics, the water tablets, an influence on potassium and magnesium is discussed. For statins a drop in the coenzyme Q10 level in blood is described, while it remains open whether a benefit of supplementation follows from it. For hormonal contraception the data on B6, B12, folate and zinc are inconsistent.
These substances are mostly prescription-only, only single acid blockers are available in low strengths without a prescription at the pharmacy. And now comes the most important sentence of this paragraph: do not stop any of these medicines on your own and do not change a dose on your own initiative. An acid blocker stopped abruptly can lead to a fierce return of the symptoms. A diabetes medicine that is stopped can send blood sugar off the rails. A statin or a diuretic that is stopped can raise again exactly the risk it was prescribed against.
So these are not arguments against these medicines. They are arguments for taking a look together with the doctor who prescribed them.
What this costs in practice in Germany
Money deserves plain speech, but not a price list. Statutory health insurance covers laboratory values when there is a concrete medical indication, meaning a justified suspicion or a follow-up check. A broad screening without symptoms usually does not fall under this and is billed as a self-pay service.
Within the self-pay world a simple rule applies: the more elaborate the procedure, the more expensive. A serum value is cheap. Intracellular measurements, methylmalonic acid, holo-transcobalamin or a fatty acid profile in erythrocytes lie clearly above that. A broad package adds up quickly.
That is why I do not think the decisive question is “what does it cost?” but “which decision depends on it?”. A value that changes nothing is too expensive even for very little money.
Three levers you can put into practice today
No panel, no shopping list, no brands. Just three things that lie in your hands.
Lever 1: formulate your question before you give blood
- Write down in one sentence what is meant to change. Exhaustion? Concentration? Hair loss? Muscle cramps? Tingling in the feet?
- Take this sentence with you to the practice. The parameters follow from the question, not the other way round.
- And ask the counter question: what happens with which result? If the answer is the same in both cases, you do not need the value.
Lever 2: make sure the conditions are comparable
- Blood draw in the morning and fasting where possible, and over time always at the same hour of the day if you can.
- Whether and how long you pause supplements before the measurement is something you clarify medically beforehand. With B12 already started, this is particularly relevant.
- Stay with the same laboratory over time. Different measurement methods otherwise create differences that do not exist in the body at all.
- Mention acute infections in the past weeks. Inflammation shifts several values at once.
Lever 3: plan the ending before you begin
- Agree with your doctor when the check will happen and how the two of you want to recognise success.
- Supplements are as a rule a time-limited measure with a goal and a review date, not a permanent subscription. There are justified exceptions, for example after stomach surgery or with chronic malabsorption.
- Do not change several things at once. Otherwise you will not know afterwards what made the difference.
This text does not replace a medical examination or individual advice. Laboratory values belong in medical interpretation, because very different causes can sit behind the same symptoms.
For higher doses this holds in particular. With reduced kidney function, minerals such as magnesium and potassium can accumulate. With liver disease the metabolism of fat soluble vitamins is altered. Vitamin K can influence the effect of vitamin K antagonists such as phenprocoumon or warfarin. Iron without a confirmed indication can do harm in certain storage diseases. Zinc taken in high doses over a longer period can push down copper uptake. In pregnancy and breastfeeding and in children, separate rules apply.
Nutrients can also interact with medicines, for example with thyroid hormones and with certain antibiotics. So discuss every planned supplement with the person who knows your findings and your medication.
And now you know why I prefer to determine three values in a targeted way rather than thirty on suspicion.
Frequent questions about micronutrient testing
What is a micronutrient analysis?
A micronutrient analysis is a laboratory test meant to estimate how well you are supplied with vitamins, minerals, trace elements and sometimes fatty acids.
It is not a uniformly defined package. Depending on the laboratory, very different parameters sit inside it, measured in very different materials: in serum, in whole blood, in red blood cells or in urine. Exactly this lack of uniformity is why two analyses carrying the same name can lead to different conclusions.
From my point of view such an analysis becomes useful when it answers a concrete question instead of producing as many numbers as possible. Before the blood draw it should be clear which decision depends on the result.
What does a micronutrient analysis cost at the family doctor?
A flat number would be dishonest, because the price depends entirely on which parameters are determined in which material.
In Germany the basic rule is: statutory health insurance covers laboratory values when there is a concrete medical indication, meaning a justified suspicion or a follow-up check. A broad screening without symptoms usually does not fall under this and is billed as a self-pay service.
Intracellular measurements in whole blood, methylmalonic acid, holo-transcobalamin or a fatty acid profile in erythrocytes are more elaborate than a simple serum value and cost accordingly more.
More useful than the question of price is the question of benefit: which decision changes because of this value?
Whole blood or serum: which micronutrient analysis makes more sense?
That depends on the nutrient, which is why the question in this form cannot be answered.
For minerals that sit mostly inside the cell, serum can reflect the body pool poorly. For magnesium, specialist reviews describe that more than 99 percent of the pool lies intracellularly and in bone, and that less than one percent floats in serum. Here whole blood or measurement in erythrocytes can add information.
At the same time whole blood has weaknesses of its own: there is no internationally accepted gold standard, the reference ranges differ between laboratories, and the haematocrit influences the result.
So whole blood is not a better value as such. It is a different angle that fits some questions better.
Which values belong in a sensible micronutrient analysis?
Instead of a fixed list I use a principle: first the question, then the parameter.
If you want to know whether an anaemia is linked to iron deficiency, you need ferritin together with an inflammation marker such as CRP, plus a blood count and transferrin saturation. If you suspect a B12 deficiency, total B12 in serum often does not take you far and you need functional markers such as holo-transcobalamin, methylmalonic acid or homocysteine.
If you want to know your fatty acid status, you measure the omega-3 index in erythrocytes and not in plasma. And if you want to know your vitamin D status, you measure 25-OH vitamin D, not the active form.
Anything that has no consequence can safely be left out.
Why is my vitamin B12 normal and I still have symptoms?
Because total B12 in serum measures both: the small biologically available share and the larger one bound to a transport protein that does not bring it into the cell.
A large evaluation of more than 11,000 blood samples compared four markers with each other and found the best discrimination for holo-transcobalamin in women aged 50 and over, while the markers differed less clearly in other groups. A further study from primary care showed that the informative value fluctuates strongly depending on the clinical question.
A normal total value therefore does not reliably rule out a functional deficiency. If your symptoms fit the picture, holo-transcobalamin and methylmalonic acid can help further.
This interpretation belongs in medical hands, because neurological symptoms can have many causes.
Why should ferritin always be measured together with CRP?
Because ferritin holds two jobs at once. It is the iron store and at the same time an acute phase protein that rises with inflammation.
That means: an infection, a silent inflammation or excess weight can push the ferritin value upwards while the iron stores are in fact empty. The international BRINDA project brought together data from 26 population surveys, mostly from countries with a high infection burden. There a raised CRP was detectable in 6 to 40 percent of the children, depending on the survey. These shares cannot be transferred to Germany, the principle can.
Without a parallel inflammation marker a single ferritin value is therefore hard to interpret.
An NHANES evaluation also suggests that the classical cut-offs could sit too low, with physiologically derived thresholds around 20 micrograms per litre in children and 25 in non-pregnant women.
One more thing matters: a newly found low ferritin value belongs in medical hands, because a blood loss can sit behind it.
Is a hair mineral analysis useful?
For judging your nutrient status it does not hold up according to the available data.
In a much cited study a single hair sample from a healthy person was split and sent to six commercial laboratories which together covered most of the US market. For twelve minerals the highest and the lowest reported value differed by more than tenfold. The reference ranges and the recommendations derived from them also contradicted each other.
The authors advised against using such analyses to judge an individual nutritional status.
For forensic or occupational medicine questions about specific pollutants, other, strictly standardised procedures apply. Those procedures were developed for a different question and are standardised differently from commercial mineral profiles.
What are IgG tests on foods worth?
For diagnosing a food allergy or an intolerance they are not suitable according to the position paper of a European specialist society.
The reason is immunological: IgG4 against foods shows that your immune system has met a food repeatedly. It counts more as a sign of tolerance than of intolerance. Many people have positive values without any symptoms at all. The society concluded that such tests should not be carried out for food-related complaints.
That does not mean your symptoms are imagined. It means that this test gives the wrong answer to a legitimate question.
More useful are structured elimination and reintroduction phases with medical guidance and a targeted work-up for coeliac disease and for lactose or fructose handling.
Do I have to fast for a micronutrient analysis?
For many parameters yes, and standardisation as a whole matters even more.
An expert panel on homocysteine measurement describes in detail how strongly sample collection and further processing can influence the result, because red blood cells keep releasing homocysteine after the draw. For zinc, an international expert panel describes that the plasma concentration is influenced by the last meal, by the time of day, by inflammation and by certain medicines and hormones.
And a haemolytic sample can distort values such as potassium considerably.
In practice that means: in the morning and fasting, and over time in the same laboratory whenever possible. Whether and for how long you pause supplements before the measurement is something you clarify medically beforehand. Otherwise you are comparing apples with oranges.
How often should micronutrients be checked?
As often as it changes a decision, and no more often than that.
In practice a simple pattern has proven itself: a baseline laboratory before you start, a check after some weeks to months, depending on the nutrient and its half-life in the body, and then a decision about continuing, adjusting or stopping.
Supplements are as a rule a time-limited measure with a goal and a review date, not a permanent subscription. There are justified exceptions, for example after stomach surgery, with chronic malabsorption or during the dark months at our latitudes.
One more thing matters: with some nutrients a high intake shifts the balance of others along with it. That is why every higher dose belongs under medical guidance.
How this topic connects with the others
Diagnostics is never an end in itself. These paths lead onwards, depending on which question brought you here.
Supplements
The guide this article belongs to
You are hereWhen supplements make sense
Control loops, and why more is not better
Orthomolecular medicine
Why the dose changes everything
Measuring B12 properly
Holo-TC, MMA and the serum value in detail
Functional iron deficiency
When the ferritin looks normal
Iron and inflammation
How hepcidin can throttle uptake
Measuring the omega-3 index
The blood value that reflects weeks
Hair mineral analysis
What it can do and what it cannot
Sources
- Workinger JL, Doyle RP, Bortz J. Challenges in the Diagnosis of Magnesium Status. Nutrients. 2018;10(9):1202. DOI: 10.3390/nu10091202 [Review]
- Jarquin Campos A, Risch L, Nydegger U et al. Diagnostic Accuracy of Holotranscobalamin, Vitamin B12, Methylmalonic Acid, and Homocysteine in Detecting B12 Deficiency in a Large, Mixed Patient Population. Dis Markers. 2020;2020:7468506. DOI: 10.1155/2020/7468506 [Cohort, n=11,833]
- Murphy MJ, Brandie F, Ebare M et al. Personalising laboratory medicine in the real world: Assessing clinical utility, by clinical indication, of serum total B12 and Active-B12 (holotranscobalamin) in the diagnosis of vitamin B12 deficiency. Ann Clin Biochem. 2021;58(5):445-451. DOI: 10.1177/00045632211003605 [Cohort, n=899]
- Oberley MJ, Yang DT. Laboratory testing for cobalamin deficiency in megaloblastic anemia. Am J Hematol. 2013;88(6):522-526. DOI: 10.1002/ajh.23421 [Review]
- Refsum H, Smith AD, Ueland PM et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004;50(1):3-32. DOI: 10.1373/clinchem.2003.021634 [Review, expert consensus]
- Reynolds EH. What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies. Eur J Clin Nutr. 2016;70(5):537-540. DOI: 10.1038/ejcn.2015.231 [Review]
- van Gool JD, Hirche H, Lax H, De Schaepdrijver L. Fallacies of clinical studies on folic acid hazards in subjects with a low vitamin B12 status. Crit Rev Toxicol. 2020;50(2):177-187. DOI: 10.1080/10408444.2020.1727842 [Review]
- Merrill RD, Burke RM, Northrop-Clewes CA et al. Factors associated with inflammation in preschool children and women of reproductive age: BRINDA project. Am J Clin Nutr. 2017;106(Suppl 1):348S-358S. DOI: 10.3945/ajcn.116.142315 [Cohort, n=55,496]
- Engle-Stone R, Aaron GJ, Huang J et al. Predictors of anemia in preschool children: BRINDA project. Am J Clin Nutr. 2017;106(Suppl 1):402S-415S. DOI: 10.3945/ajcn.116.142323 [Cohort, n=29,293]
- Mei Z, Addo OY, Jefferds ME et al. Physiologically based serum ferritin thresholds for iron deficiency in children and non-pregnant women: a US NHANES serial cross-sectional study. Lancet Haematol. 2021;8(8):e572-e582. DOI: 10.1016/S2352-3026(21)00168-X [Cohort, n=10,067]
- King JC, Brown KH, Gibson RS et al. Biomarkers of Nutrition for Development (BOND) Zinc Review. J Nutr. 2016;146(4):858S-885S. DOI: 10.3945/jn.115.220079 [Review, expert panel]
- Schomburg L. Selenoprotein P, Selenium transport protein, enzyme and biomarker of selenium status. Free Radic Biol Med. 2022;191:150-163. DOI: 10.1016/j.freeradbiomed.2022.08.022 [Mechanism Review]
- Binkley N, Carter GD. Toward Clarity in Clinical Vitamin D Status Assessment: 25(OH)D Assay Standardization. Endocrinol Metab Clin North Am. 2017;46(4):885-899. DOI: 10.1016/j.ecl.2017.07.012 [Review]
- Harris WS, Del Gobbo L, Tintle NL. The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies. Atherosclerosis. 2017;262:51-54. DOI: 10.1016/j.atherosclerosis.2017.05.007 [Meta-analysis, k=10 cohorts]
- Bittner DO, Goeller M, Zopf Y, Achenbach S, Marwan M. Early-onset coronary atherosclerosis in patients with low levels of omega-3 fatty acids. Eur J Clin Nutr. 2020;74(4):651-656. DOI: 10.1038/s41430-019-0551-5 [Cohort, n=71]
- Seidel S, Kreutzer R, Smith D, McNeel S, Gilliss D. Assessment of commercial laboratories performing hair mineral analysis. JAMA. 2001;285(1):67-72. DOI: 10.1001/jama.285.1.67 [Real-World, laboratory comparison, k=6 laboratories]
- Stapel SO, Asero R, Ballmer-Weber BK et al. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report. Allergy. 2008;63(7):793-796. DOI: 10.1111/j.1398-9995.2008.01705.x [Review, professional society statement]
- Nikolac Gabaj N, Miler M, Vrtaric A et al. Comparison of three different protocols for obtaining hemolysis. Clin Chem Lab Med. 2022;60(5):714-725. DOI: 10.1515/cclm-2021-1227 [In vitro, human serum samples]
- Bhargava S, Singla P, Manocha A et al. The Hemolyzed Sample: To Analyse Or Not To Analyse. Indian J Clin Biochem. 2020;35(2):232-238. DOI: 10.1007/s12291-019-00821-4 [In vitro, human serum samples, n=25]
- Talwar D, Catchpole A, Wadsworth JM, Toole BJ, McMillan DC. The relationship between plasma albumin, alkaline phosphatase and pyridoxal phosphate concentrations in plasma and red cells: Implications for assessing vitamin B6 status. Clin Nutr. 2020;39(9):2824-2831. DOI: 10.1016/j.clnu.2019.12.012 [In vitro, human whole blood, n=34]